Results 51 to 60 of about 226 (74)
PP142 Health Technology Assessment – A Major Bottleneck In Patient Access?
International Journal of Technology Assessment in Health Care, 2019 IntroductionConditional marketing authorization (CMA) and accelerated assessment (AA) have been introduced to expedite the development of and access to therapies in Europe. However, to reach patients medicines must also be publicly reimbursed. This research evaluated the reimbursement of therapies which have received European CMA or underwent AA ...
George Wang, Richard Macaulay
openaire +2 more sources
PP142 Is Insulin Therapy Important For The Quality Of Life Of Diabetics?
International Journal of Technology Assessment in Health Care, 2018 Introduction:Quality of life (QoL) is an important health measure and is widely used to assess the difference between treatments for Type 1 Diabetes Mellitus (T1DM) since the desirable glycemic control and the minimization of episodes of hypoglycemia are fundamental aspects for a better QoL.
Paulo Henrique Ribeiro Fernandes Almeida +10 more
openaire +2 more sources